Key result
A systematic framework incorporating duration of symptoms and anticipated transport delays guides the selection of primary PCI versus thrombolytic therapy for STEMI patients.
Why the study?
What is the optimal reperfusion strategy (primary PCI vs thrombolytic therapy) for patients with ST-segment elevation myocardial infarction presenting to non-PCI capable hospitals?
What is the optimal reperfusion strategy (primary PCI vs thrombolytic therapy) for patients with ST-segment elevation myocardial infarction presenting to non-PCI capable hospitals?
This review provides a practical framework for clinicians to choose between primary PCI and thrombolytic therapy for STEMI patients based on ischemia time and transport delays.
Answers are grounded in this paper and cite their sources.
May aid reperfusion decisions at non-PCI hospitals; leaves open prospective validation of the symptom- and delay-based algorithm.
Optimal treatment for ST-segment elevation myocardial infarction depends on early diagnosis and rapid selection of the appropriate reperfusion strategy. Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy at PCI-capable hospitals. For hospitals without PCI capability, there are 2 reperfusion strategies, primary PCI and thrombolytic therapy, which are both supported by clinical evidence and national guidelines. Transferring patients for primary PCI may cause delays and requires established, proven protocols, systems, and networks to achieve minimal door-to-balloon times. The authors review the available data and present a systematic, evidence-based approach in a simple framework to enable noncardiovascular and cardiovascular physicians to select the optimal reperfusion strategy. The framework is based on available data from clinical trials and local circumstances from clinical practice by incorporating duration of symptoms (fixed ischemia time) and anticipated transport delays to a PCI-capable facility (incurred ischemia time).
No takes yet. Share an insight, caveat, or question.
Ting et al. (2006) conducted a review in ST-Segment Elevation Myocardial Infarction. Reperfusion strategies (primary PCI and thrombolytic therapy) was evaluated. A systematic framework incorporating duration of symptoms and anticipated transport delays guides the selection of primary PCI versus thrombolytic therapy for STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: